Limitations Not yet FDA-approved (as of 2025)
With increasing clinical evidence, GLP-1RAs are set to become essential in treating complex and chronic diseases, offering significant health benefits and addressing unmet medical needs, thus enhancing patient quality of life and solidifying their role in future medical advancements
The study involved 338 adults with obesity (no diabetes) and compared weekly Retatrutide injections against placebo over 48 weeks
In fact her boss, Mads Krogsgaard Thomsen, remembers that top management gave them only one year 'to come up with a GLP-1 candidate for daily administration to people with type 2 diabetes' (Holst 2024)
Heres how it helps: Help your body use insulin, which keeps your blood sugar in balance Make you feel full and stop you from overeating Tell your brain that youve had enough food So, GLP-1 plays a major role in controlling your hunger and helping your body process food properly
Some plans cover obesity medications with prior authorization
-the-right-way-seo-graphics-gs.png?sfvrsn=5784682_3)
